CAS: 872599-83-2 - (3R,6R)-3-(2,3-Dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
Fórmula:C30H38N4O4
InChI:InChI=1S/C30H38N4O4/c1-5-18(2)26-28(35)32-25(23-16-21-8-6-7-9-22(21)17-23)29(36)34(26)27(24-11-10-19(3)31-20(24)4)30(37)33-12-14-38-15-13-33/h6-11,18,23,25-27H,5,12-17H2,1-4H3,(H,32,35)/t18-,25+,26+,27+/m0/s1
Clave InChI:InChIKey=UWHCWRQFNKUYCG-QUZACWSFSA-N
SMILES:O=C1NC(C(=O)N(C(C(=O)N2CCOCC2)C3=CC=C(N=C3C)C)C1C(C)CC)C4CC=5C=CC=CC5C4
- Sinónimos:
- Morpholine, 4-[(2R)-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-[(1S)-1-methylpropyl]-2,5-dioxo-1-piperazinyl](2,6-dimethyl-3-pyridinyl)acetyl]-
- (3R,6R)-3-(2,3-Dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
- GSK 557296
- Epelsiban
- 2,5-Piperazinedione, 3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-, (3R,6R)-
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Epelsiban REF: 3D-XJB59983CAS: 872599-83-2 | Min. 95% | A consultar | Mar 07 Ene 25 | |
Epelsiban REF: TM-T11502CAS: 872599-83-2 | 98% | 1.277,00 €~3.447,00 € | Lun 27 Ene 25 |
Epelsiban
Ref: 3D-XJB59983
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Epelsiban
Ref: TM-T11502
25mg | 1.967,00 € | ||
50mg | 2.590,00 € | ||
100mg | 3.447,00 € |